Vanda Pharmaceuticals (VNDA) Interest & Investment Income (2010 - 2023)

Vanda Pharmaceuticals (VNDA) posted Interest & Investment Income of -$51000.0 for Q4 2023, down 151.52% sequentially from $99000.0 in Q4 2011.

Analysis

Vanda Pharmaceuticals (VNDA) Interest & Investment Income (2010 - 2023) Analysis & Trends

Vanda Pharmaceuticals has reported Interest & Investment Income for 3 years, with the latest figure at -$51000.0 in Q4 2023.

Quarterly Interest & Investment Income changed N/A year-over-year to -$51000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$51000.0 (changed N/A YoY) and the FY2023 annual result came in at -$51000.0, changed N/A from the prior year.
Interest & Investment Income eased to -$51000.0 in Q4 2023 per VNDA's latest filing, from $99000.0 in the prior quarter.
Over five years, Interest & Investment Income peaked at -$51000.0 in Q4 2023 and troughed at -$51000.0 in Q4 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	120.60 Mn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-48.00 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	48.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	67.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	35.58 Mn
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	27.90 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	28.14 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	5.13 Mn
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	10.98 Mn
10	Vanda Pharmaceuticals	327.03 Mn	157.00 Mn	46.97 Mn	-

Historic Data

Download Data